These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Eyelid metastases indicating neuroendocrine carcinoma of unknown origin. Bachmeyer C; Henni AM; Cazier A; Putterman M; Morel X Eye (Lond); 2004 Jan; 18(1):94-5. PubMed ID: 14707982 [No Abstract] [Full Text] [Related]
48. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement. Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225 [TBL] [Abstract][Full Text] [Related]
49. [Ocular metastases of solid extraocular tumors. Frequency of ocular metastases and localization of the primary tumors]. Królewska K; Palacz O; Zajaczek S Klin Oczna; 2004; 106(1-2):102-6. PubMed ID: 15218777 [TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical staining and malignancies of unknown primary origin. Turney J; Daroca P; Brown J; Jaffe BM J La State Med Soc; 2012; 164(2):83-6. PubMed ID: 22685858 [No Abstract] [Full Text] [Related]
53. Cutaneous metastases from a hypopharyngeal malignancy. Durvasula VS; Mahendran S; Grant JW; Jani P J Laryngol Otol; 2005 Apr; 119(4):319-21. PubMed ID: 15949091 [TBL] [Abstract][Full Text] [Related]
54. Pulmonary metastases of breast cancer. When is resection indicated? Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371 [TBL] [Abstract][Full Text] [Related]
55. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
56. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer. Skírnisdóttir I; Garmo H; Holmberg L Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826 [TBL] [Abstract][Full Text] [Related]
57. Multiple cutaneous metastases from male breast carcinoma. Karakuzu A; Koc M; Ozdemir S J Am Acad Dermatol; 2006 Dec; 55(6):1101-2. PubMed ID: 17097408 [TBL] [Abstract][Full Text] [Related]
58. [Cancer of unknown primary site origin--advances in diagnosis and therapy]. Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808 [TBL] [Abstract][Full Text] [Related]
59. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
60. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]